Physician profile
Mark Pyfer
NPI 1164059986
$5,050.32
in general payments reported to CMS, 2019-2025
15 companies · $3,041 in 2025
The $3,041 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,009 · 2025: $3,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,550 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,550.32 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $1,500.00 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope |
| Alcon Vision LLC | $1,016.55 | 2024-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Tarsus Pharmaceuticals, INC. | $394.31 | 2024-2025 | Xdemvy |
| Abbvie INC. | $338.14 | 2024-2025 | |
| Biotissue Holdings INC. | $306.59 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $288.46 | 2024-2025 | |
| Glaukos Corporation | $204.91 | 2024 | Idose, Ce-Marked Kxla System |
| Sight Sciences, INC. | $169.97 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Dompe US, INC. | $168.11 | 2024-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $159.44 | 2025 | Catalys System |
| Bausch & Lomb Americas INC. | $144.63 | 2024 | Envista Mx60 Iol, Totalvisc, Stellaris |
| Rxsight INC | $126.09 | 2024-2025 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Harrow Eye, LLC | $117.71 | 2024-2025 | Vevye |
| Amgen INC. | $94.50 | 2024 | Tepezza |
| New World Medical,INC. | $20.91 | 2025 | Streamline, Via360, Kahook Dual Blade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Pyfer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.